Parallax Volatility Advisers
AMPH icon

Parallax Volatility Advisers’s Amphastar Pharmaceuticals AMPH Stock Holding History

Parallax Volatility Advisers’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-5,544
Closed -$107K – 2201
2017
Q4 		$107K Buy
+5,544
New +$104K ﹤0.01% 2762

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Parallax Volatility Advisers's AMPH Position: Q1 2018 in Review

Parallax Volatility Advisers sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2018, closing a stake of 5,544 shares — an estimated $107K sold.

Parallax Volatility Advisers first reported a position in AMPH in Q4 2017 and held it in 1 quarter. The position peaked at $107K in Q4 2017. 116 funds tracked by Wall St. Rank hold AMPH as of Q1 2018.

  • Parallax Volatility Advisers reported no remaining Amphastar Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 5,544 Amphastar Pharmaceuticals shares in Q1 2018, an estimated $107K.
  • Parallax Volatility Advisers first reported a position in Amphastar Pharmaceuticals in Q4 2017 and held it in 1 quarter.
  • Parallax Volatility Advisers's Amphastar Pharmaceuticals position peaked at $107K in Q4 2017.
  • 116 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2018.

Based on Parallax Volatility Advisers's 13F filing for Q1 2018, filed 15 May 2018.